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Background: Following a train derailment, several tons of acrylonitrile (ACN) exploded, inﬂamed and part
of the ACN ended up in the sewage system of the village of Wetteren. More than 2000 residents living in
the close vicinity of the accident and along the sewage system were evacuated. A human biomonitoring
study of the adduct N-2-cyanoethylvaline (CEV) was carried out days 14–21 after the accident.
Objectives: (1) To describe the short-term health effects that were reported by the evacuated residents
following the train accident, and (2) to explore the association between the CEV concentrations, extra-
polated at the time of the accident, and the self-reported short-term health effects.
Methods: Short-term health effects were reported in a questionnaire (n¼191). An omnibus test of in-
dependence was used to investigate the association between the CEV concentrations and the symptoms.
Dose-response relationships were quantiﬁed by Generalized Additive Models (GAMs).
Results: The most frequently reported symptoms were local symptoms of irritation. In non-smokers,
dose-dependency was observed between the CEV levels and the self-reporting of irritation (p¼0.007)
and nausea (p¼0.007). Almost all non-smokers with CEV concentrations above 100 pmol/g globin re-
ported irritation symptoms. Both absence and presence of symptoms was reported by non-smokers with
CEV concentrations below the reference value and up to 10 times the reference value. Residents who
visited the emergency services reported more symptoms. This trend was seen for the whole range of CEV
concentrations, and thus independently of the dose.
Discussion and conclusion: The present study is one of the ﬁrst to relate exposure levels to a chemical
released during a chemical incident to short-term (self-reported) health effects. A dose-response relation
was observed between the CEV concentrations and the reporting of short-term health effects in the non-Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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K. Simons et al. / Environmental Research 148 (2016) 256–263 257smokers. Overall, the value of self-reported symptoms to assess exposure showed to be limited. The
results of this study conﬁrm that a critical view should be taken when considering self-reported health
complaints and that ideally biomarkers are monitored to allow an objective assessment of exposure.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In the night of Saturday May 4, 2013, a train transporting bu-
tadiene, triethylaluminium and acrylonitrile (ACN) derailed in the
village of Wetteren (Belgium). Several rail tank cars with ACN
exploded and a ﬁre developed. Toxic fumes of ACN as well as hy-
drogen cyanide and nitrogen oxides were released due to the ﬁre-
induced decomposition of ACN (Van Nieuwenhuyse et al., 2014; De
Smedt et al., 2014). To avoid explosion of the rail tank cars with
butadiene and triethylaluminium, water was used to extinguish
the ﬁre and to cool the intact rail tanks. This water partly passed
into the stream along the railway track and ended up in the sewers
which resulted in a further distribution of ACN. This atypical se-
quence of events resulted in the evacuation of more than 2000
residents living in the close vicinity of the accident and along the
sewage system. The duration of the evacuation period varied from
3 days up to 3 weeks, mainly depending on the distance from the
residence to the accident site. One resident living next to the
sewage system died and two other residents experienced life-
threatening symptoms. In total, around two hundred inhabitants
of Wetteren presented at the emergency services of the sur-
rounding hospitals between May 4 and 14.
Both the physicochemical and toxicological properties of ACN
are responsible for the impact of the train derailment. ACN
(C3H3N) is a monomer used as an intermediate in the manu-
facturing of acrylic ﬁbres, styrene plastics, and adhesives. At room
temperature, ACN is a volatile, ﬂammable, water-soluble, colour-
less liquid with a garlic or onion-like odour (EU Risk Assessment
Report, 2004). ACN vapours are heavier than air and may thus
travel along the ground over a long distance. Absorption of ACN
may occur by inhalation, dermal contact, or oral ingestion and is
rapid and extensive (Kedderis et al., 1993; Pilon et al., 1988; van
Hooidonk et al., 1986). Following absorption, ACN is readily dis-
tributed throughout the body (Sandberg and Slanina, 1980). There
is no evidence for signiﬁcant accumulation of the substance itself
in any organ. However, ACN can react at electrophilic sites of en-
dogenous macromolecules, e.g. haemoglobin (Hb) proteins, and
thus can generate adducts. Hb adducts accumulate during the life
span of the red blood cells and thus can reﬂect the exposure
during the past 4 months. Metabolism of ACN primarily takes
place by two pathways (Gargas et al., 1995; Burka et al., 1994;
Kedderis et al., 1993; Fennell et al., 1991; Dahl and Waruszewski,
1989), i.e. (i) conjugation with glutathione and (ii) oxidation by the
cytochrome P450 isoenzyme CYP2E1. The ﬁrst pathway results in
the formation of an ACN-glutathione conjugate which will be
further converted into a mercapturic acid, representing the ﬁnal
urinary excretion product. Consequently, this pathway is generally
considered to be a detoxiﬁcation step. Within the second pathway,
the epoxide 2 cyanoethylene oxide (CEO) is formed as a primary
metabolite. CEO is mutagenic and therefore this metabolic path-
way is considered as the activation step. CEO can also undergo
extensive secondary metabolism which includes the interaction
with glutathione forming a series of cysteine or N-acetyl cysteine
derivatives and the production of the highly toxic metabolite cy-
anide through the action of epoxide hydrolase. Cyanide can be
detoxiﬁed by the mitochondrial enzymes rhodanese and mer-
captopyruvate S-transferase to thiocyanate and excreted in theurine. The principal route of elimination for ACN, administered by
oral or other routes, and its metabolites is urine with smaller
amounts excreted in either the faeces or exhaled breath (Kedderis
et al., 1993; Tardif et al., 1987; Ahmed et al., 1983). Acute toxicity of
ACN mainly includes respiratory and neurological symptoms. ACN
is an acute respiratory tract irritant causing effects such as irrita-
tion of the mucous membranes of the nose, eyes and upper re-
spiratory tract. More serious exposures may lead to respiratory
arrest and even death. Neurological symptoms may include limb
weakness, dizziness, nausea and vomiting, headache, tremor,
convulsions, coma and eventually death. The mode of action for
neurological effects may involve both the parent chemical and the
release of cyanide during metabolism. The mode of action for ir-
ritation effects is not known but may involve the binding of ACN or
its primary metabolite to cellular macromolecules or depletion of
tissue glutathione levels (ATSDR, 1990; WHO, 2002; AN Group,
2004).
Biomonitoring has been revealed as a powerful tool for the
individual exposure assessment and risk estimation for citizens
and rescue workers affected by chemical incidents (Müller et al.,
2014, Scheepers et al., 2014). Particularly, Hb adducts excel for this
task because of their long half-live, which enables exposure esti-
mation also from samples withdrawn several days or weeks after
the exposure scenario (Bader et al., 2014; Kloth et al., 2014; Leng
and Gries, 2014).
We previously reported on the ACN exposure of the residents
and emergency responders in a biomonitoring study in which N-2-
cyanoethylvaline (CEV) in the venous blood was monitored (De
Smedt et al., 2014; Van Nieuwenhuyse et al., 2014). CEV is the
adduct formed by reaction of ACN with the N-terminal valine in
human globin. This adduct is highly speciﬁc for exposure to ACN
and, because it is built in erythrocytes, follows zero order kinetics
after a single exposure event, gradually disappearing as the ery-
throcyte pool is being replaced, i.e. after 126 days in humans
(Granath et al., 1992, Bader et al., 2014). Based on the CEV con-
centrations measured in blood, values were extrapolated by back-
calculation to the concentrations that were to be expected at the
time of the accident, i.e. May 4, using the formula: extrapolated
CEV¼measured CEV/(1t0.008), where “t” is the number of
days between the accident and the blood sampling (Granath et al.,
1992; Bader and Wrbitzky, 2006). As smoking is a known con-
founder for ACN exposure, cotinine measurements in urine were
used to differentiate (Benowitz, 1996) between smokers (urinary
cotinine4100 mg/L) and non-smokers (urinary cotinineo25 mg/L).
For those in between, the smoking status was determined based
on the self-reported questionnaire: ‘smokers’ and ‘occasional
smokers’ were categorised as ‘smokers’, and ‘ex-smokers’ and
‘non-smokers’ as ‘non-smokers’. Within these manuscripts, health
effects of ACN exposure were not considered.
The objectives of the present study are therefore (1) to describe
the short-term health effects that were reported by the evacuated
residents following the train accident, and (2) to explore the as-
sociation between the extrapolated CEV concentrations and the
self-reported short-term health effects.
Fig. 1. Study area for the biomonitoring study in the local population. Legend of Fig. 1: Train accident. Railroad. Sewage system. Prevailing
wind directions at the moment of and in the days following the accident. Zone 1 (EZ1): 250 m perimeter of the evacuation zone that was evacuated at night in the
hours following the accident. Zone 2 (EZ2): streets parallel with the sewage system and downwind of the train accident that were evacuated later, i.e. in the days
following the accident.
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2.1. Study population and methods
The evacuation zone (EZ) was deﬁned by the Crisis Manage-
ment Cell. The different zones are depicted in Fig. 1. Zone
1 corresponds to the 250 m perimeter of the EZ that was evac-
uated at night in the hours immediately following the accident.
Zone 2 was evacuated later, i.e. in the three days following the
accident, and included the streets parallel to the sewage system
and the streets downwind of the train accident. Three groups of
adult inhabitants of the EZ were invited to participate in the bio-
monitoring study. A ﬁrst group consisted of residents of zone 1
(group ‘EZ1’). A second group consisted of residents of zone 2 that
were known to have presented at the emergency services of the
surrounding hospitals (group ‘EZ2 Emerg’). A third group consisted
of a sample of the residents of zone 2 that had been evacuated, but
had not visited the emergency services (group ‘EZ2 Evac’). A
sample of 10% of the households was taken and, within each
household, one resident was invited to participate in the biomo-
nitoring program, i.e. the person who was the ﬁrst to have his
birthday following the accident. In case the selected person was
unable to attend the sampling, another member of the household
was offered to participate in the biomonitoring program.
The biomonitoring study was carried out between May 18 and
25 2013 (days 14 till 21 after the accident). CEV adducts in venous
blood were measured by a modiﬁed Edman degradation (Van
Sittert et al., 1997; Tornqvist et al., 1986) and cotinine in the urine
by online-SPE-UPLCs-MS/MS (De Cremer et al., 2013). The study
protocol was approved by the Ethical Committee of Ghent Uni-
versity Hospital. An informed consent was signed by all partici-
pants prior to their participation in the study and the study wascompleted in accordance with the Helsinki declaration. In the
evacuated zones, 197 residents participated in the biomonitoring
study (participation rate of 55%). Out of these 197 residents, 191
also ﬁlled in the questionnaire with health symptoms. These 191
residents constitute the study population of the current study. The
participation rates in EZ1 and in EZ2 Emerg were 65.0% and 47.5%,
respectively. Of the eligible persons in EZ2 (one resident in a 10%
sample of the households), 53.9% participated. Table 1 presents the
descriptive statistics of the study population. Fifty-ﬁve persons
were smokers and 136 were non-smokers. The median age in non-
smokers was 49 years and 51 (37.5%) were men. In non-smokers,
median CEV concentrations were similar between the three
groups of residents. However, the variation was different, with a
larger proportion of residents with high CEV concentrations in the
groups that were evacuated later. In the group ‘EZ2 Emerg’, the
95th percentile and maximum were 2761 and 12,615 pmol/g glo-
bin, respectively. In the group ‘EZ2 Evac’, the 95th percentile and
the maximum were 340 and 2129 pmol/g globin. In smokers, the
median age was 40 years and 29 (52.7%) were men. No differences
in CEV concentrations among the subgroups were observed in
smokers.
2.2. Self-reported short-term health effects
Short-term health effects were assessed by means of a ques-
tionnaire distributed at the time of blood and urine collection, i.e.
days 14–21 after the accident. A predeﬁned list of health effects
that have been described in relation to ACN exposure in literature
(Vleminckx et al., 2014) was given to the participants. They were
asked to ﬁll in to what degree they had experienced each health
effect following the accident: ‘no symptoms’, ‘moderate symp-
toms’, and ‘serious symptoms’. The following health effects were
Table 1
Characteristics of the local study population in the evacuated zone of the train
accident (n¼191).
Non-smokers
EZ1
(n¼20)
EZ2 Emerg
(n¼33)
EZ2 Evac
(n¼83)
Total
(n¼136)
Age (years), Median
(IQR)
58.00
(39.75–
69.25)
49.50
(35.00–
58.00)
48.00
(34.00–
62.50)
49.00
(35.00–
64.00)
Men n (%) 8 (40%) 12 (36.4%) 31 (37.3%) 51 (37.5)
Extrapolated CEV
(pmol/g globin)
Median (IQR) 9.9 (4.0–
14.4)
8.0 (5.7–
67.6)
6.8 (3.4–
14.7)
6.9 (3.4–
16.2)
95th percentile 35.9 2760.6 74.7 623.3
Maximum 64.8 12,614.9 1461.4 12,614.9
4ref value n
(%)
10 (50.0) 13 (39.4) 27 (32.5) 50 (36.8)
Smokers
EZ1 (n¼6) EZ2 Emerg
(n¼14)
EZ2 Evac
(n¼35)
Total
(n¼55)
Age (years), Median
(IQR)
45.50
(35.50–
48.75)
37.00
(33.75–
48.75)
40.00
(31.00–
54.00)
40.00
(32.00–
53.50)
Men n (%) 4 (66.7%) 7 (50.0%) 18 (51.4%) 29 (52.7%)
Extrapolated CEV
(pmol/g globin)
Median (IQR) 230.3 (/) 185.8
(105.3–
287.5)
174.3
(141.6–
264.6)
183.0
(149.5–
272.5)
95th percentile / 355.6 477.3 402.4
Maximum 337.5 373.9 694.8 694.8
4ref value n
(%)
2 (33.3) 6 (42.9) 14 (40.0) 22 (40.0)
EZ1 – Residents of zone 1 of the EZ, i.e. the 250 m perimeter of the EZ that was
evacuated at night in the hours immediately following the accident.
EZ2 – Residents of zone 2 of the EZ, i.e. the streets parallel with the sewage system
and downwind of the train accident that was evacuated in the days following the
accident.
EZ2 Emerg – Residents of EZ2 that were known to have presented at the emergency
services.
EZ2 Evac – Residents of EZ2 that were evacuated, but did not visit the emergency
services. A sample of 10% of the households was taken and, within each household,
one resident was invited to participate in the biomonitoring program, i.e. the
person who was the ﬁrst to have his birthday following the accident. In case the
selected person was unable to attend the sampling, another member of the
household was offered to participate in the biomonitoring program.
IQR¼ interquartile range.
CEV – N-2-cyanoethylvaline.
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tation of the nose, throat or airways, headache, nausea, and tre-
mor. Participants could also indicate if they had experienced
‘other’ health effects than the ones mentioned and, in that case,
describe their symptoms.
For the analyses, four categories of symptoms were created:
(i) irritation (Category 1) including coughing, eye irritation, skinirritation, and irritation of the nose, throat or airways; (ii) head-
ache (Cat 2); (iii) nausea (Cat 3); and (iv) tremor (Cat 4). Pre-
valence of these symptom categories was calculated, stratiﬁed by
smoking status (‘smoker’ – ‘non-smoker’) and subgroup (‘EZ1’, ‘EZ2
Emerg’, ‘EZ2 Evac’). Because the relationship between ACN ex-
posure and symptoms in humans has not been studied before and
there is a lack of data to rely on, a non-parametric approach was
chosen to explore the association between CEV concentrations and
self-reported symptoms. Analyses were carried out separately for
non-smokers and smokers. ‘Moderate’ and ‘serious’ symptoms
were collapsed into one category to increase statistical power. In a
ﬁrst step, the independence between the CEV concentrations and
all symptom categories together was tested, using an omnibus test
of independence based on the sample distance covariance (Szekely
et al., 2007). In a second step, the same test was applied to verify
independence between ACN exposure and each category of
symptoms separately. In a last step, the dose-response relationship
between the CEV concentrations and the short-term health effects
was quantiﬁed for each symptom that was signiﬁcant in Step 2. To
this purpose, Generalized Additive Models (GAMs) were used.
GAMs (Hastie and Tibshirani, 1990) are regression models that do
not make assumptions on the format of the dose-response re-
lationship itself (non-parametric part), but they do allow to ac-
count for different baseline risks in function of the subgroups
(parametric part). This was necessary because the baseline risk for
reporting symptoms showed to be different by subgroup (see
further). As such, for each signiﬁcant symptom of Step 2, a GAM
model was ﬁtted with the following linear predictor:
π
π
( ) = ( ) + + +
~ ( )
logit f exposure group group group
y Binomial ,
a b c
where the logit link function is used with the symptom risk π as
the outcome y is binary, f is a smooth function of the exposure
using thin-plate splines, and there are three dummy variables for
the three subgroups.3. Results
3.1. Self-reported symptoms following the train accident (Table 2)
The most prevalent symptoms in the 191 evacuated partici-
pants were irritation (48.5% in non-smokers and 65.5% in smokers)
and headache (39.0% in non-smokers and 56.4% in smokers).
Nausea and tremor were reported by 16.2% and 5.1% of the non-
smokers, respectively. In smokers, the prevalence of nausea and
tremor were both 12.7%. Both in non-smokers and smokers, nose,
throat and airways problems were the most prevalent irritation
complaints, followed by eye irritation and coughing. Skin irritation
was reported by 5% or less of the participants. In non-smokers,
health symptoms were reported more frequently by the residents
who had presented at the emergency services (EZ2 Emerg),
whereas a mixed pattern was seen in smokers.
3.2. Association between CEV concentrations and short-term health
effects
3.2.1. Testing for independence (Table 3)
In the group of smokers, no association was seen between the
CEV concentrations and the four symptom categories together
(p¼0.400). In non-smokers, however, dose-dependency was ob-
served between ACN exposure at the time of the train accident and
the self-reporting of short-term health effects (p¼0.007).
When testing for each symptom category separately in non-
smokers, the distance-covariance test gave signiﬁcant results for
12
3
4
Table 2
Self-reported symptoms of the study population in the evacuated zone of the train
accident (n¼191).
Non-smokers
EZ1
(n¼20)
EZ2 Emerg
(n¼33)
EZ2 Evac
(n¼83)
Total
(n¼136)
n (%) n (%) n (%) n (%)
Irritation (Cat1) 9 (45.0) 25 (75.8) 32 (38.6) 66 (48.5)
Headache (Cat2) 5 (25.0) 19 (57.6) 29 (34.9) 53 (39.0)
Nausea (Cat3) 3 (15.0) 14 (42.4) 5 (6.0) 22 (16.2)
Tremor (Cat4) 2 (10.0) 2 (6.1) 3 (3.6) 7 (5.1)
Reported complaints of irritation
(Cat1)
Coughing 6 (30.0) 9 (27.3) 10 (12.0) 25 (18.4)
Eye irritation 2 (10.0) 8 (24.2) 16 (19.3) 26 (19.1)
Skin irritation 0(0.0) 3 (9.1) 2 (2.4) 5 (3.7)
Irritation of the
nose, throat, and
airways
5 (25.0) 17 (51.5) 21 (25.3) 53 (31.6)
Smokers
EZ1
(n¼6)
EZ2 Emerg
(n¼14)
EZ2 Evac
(n¼35)
Total
(n¼55)
n (%) n (%) n (%) n (%)
Irritation (Cat1) 5 (83.3) 12 (85.7) 19 (54.3) 36 (65.5)
Headache (Cat2) 5 (83.3) 8 (57.1) 18 (51.4) 31 (56.4)
Nausea (Cat3) 1 (16.7) 3 (21.4) 3 (8.6) 7 (12.7)
Tremor (Cat4) 1 (16.7) 3 (21.4) 3 (8.6) 7 (12.7)
Reported complaints of irritation (Cat1)
Coughing 4 (66.7) 6 (42.9) 7 (20.0) 17 (30.9)
Eye irritation 3 (50.0) 5 (35.7) 10 (28.6) 18 (32.7)
Skin irritation 0 (0.0) 0 (0.0) 3 (8.6) 3 (5.5)
Irritation of the
nose, throat, and
airways
3 (50.0) 10 (71.4) 16 (45.7) 29 (52.7)
Table 3
Association between CEV concentrations and self-reported symptoms in the
evacuated residents.
Null hypothesis of independencya (P
value)
Non-smokers
(n¼136)
Smokers (n¼55)
Irritation or headache or nausea or
tremor
0.007 0.400
Irritation (Cat 1) 0.007 /
Headache (Cat 2) 0.882 /
Nausea (Cat 3) 0.007 /
Tremor (Cat 4) 0.081 /
a Omnibus test based on the sample distance covariance.
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were non-signiﬁcant for headache (Cat2, p¼0.882) and tremor
(Cat4, p¼0.081); hence, these symptom categories were not ex-
plored further.
3.2.2. Quantiﬁcation of the dose-response relationship
For each subgroup of non-smokers, the dose-response re-
lationship was estimated between the CEV concentrations at thetime of the accident and the reporting of irritation (Cat1) and
nausea (Cat3). Fig. 2a and b show the results for irritation (Cat1)
and nausea (Cat3), respectively. For information, the scatterplots
are added in Fig. 3. From Fig. 2, the following results were found:
) The dose-response relationship between the CEV concentra-
tions in the blood of the residents at the time of the accident
and the reporting of irritation and nausea was best ﬁtted by a
monotonously increasing relation.
) The probability to report symptoms by residents with CEV
concentrations below the reference value of 10 pmol/g globin
(Kraus et al., 2016), further called ‘the baseline risk’, was not
zero. The baseline risk was higher for irritation than for nausea.
This observation already became clear from the scatterplots
(Fig. 1): irritation and nausea were also reported by residents
with CEV concentrations below the reference value of 10 pmol/g
globin, although reporting was more pronounced for irritation.
This lack of pattern was clear up to CEV concentrations of
100 pmol/g globin.
) For residents with high CEV concentrations, i.e. 100 pmol/g
globin or higher, the probability to report symptoms was very
high for irritation, but remained lower for nausea. This pattern
can also be seen in the scatterplots (Fig. 3): almost all residents
with CEV concentrations above 100 pmol/g globin reported
irritation symptoms. Nausea was less reported, even when
residents had high CEV concentrations.
) The probability to report symptoms differed clearly among the
subgroups; it was highest in the group EZ2 Emerg. In the groups
EZ2 Evac and EZ1, the probability to report symptoms was si-
milar, but lower as compared to EZ2 Emerg. The broadest range
of CEV concentrations was also observed in the EZ2 Emerg
group (ranging from 1.3 up to 12,610.0 pmol/g globin) as com-
pared to EZ2 Evac (1.3 up to 1461.0 pmol/g globin) and EZ1 (1.3
up to 64.8 pmol/g globin). More symptoms were reported in the
EZ2 Emerg group. This trend was observed for the whole range
of CEV concentrations, and thus independently of the dose.4. Discussion and conclusions
The most prevalent complaints in the evacuated residents were
local symptoms of irritation. This is in line with literature, irrita-
tion being an important effect of ACN (EU Risk assessment Report,
2004). Almost all non-smokers with CEV concentrations above
100 pmol/g globin reported irritation symptoms. Irritation can
thus be considered as a rather sensitive symptom for more pro-
nounced ACN exposures in non-smokers. However, irritation was
also substantially reported by non-smokers with CEV concentra-
tions below the reference value of 10 pmol CEV/g globin. This was
somewhat unexpected, as non-smokers with CEV concentrations
below the reference value are considered to fall within the 95th
percentile of a non-exposed population. The symptom reporting in
non-exposed people renders irritation a non-speciﬁc symptom for
lower ACN exposures. The inconsistent reporting of symptoms was
observed up to CEV concentrations of 10 times the reference value.
Several hypotheses may be put forward to explain the reporting of
symptoms in non-exposed people and people exposed to low
concentrations of ACN. First, some residents may have experienced
very short peak exposures to ACN that are not reﬂected by the
adduct biomonitoring due to its low temporal resolutions. Second,
other vapours (not ACN) and dusts in connection with the accident
might have provoked these symptoms. In non-smokers with CEV
concentrations below 100 pmol/g globin who reported irritation,
the most reported complaints were coughing (43.6%) and irritation
of the nose, throat and airways (70.9%) (additional analyses, results
not shown). Upper airway irritation may point very well to the
Fig. 2. Dose-response relationship between the CEV concentrations at the time of the accident and short-term health effects.
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train accident, it needs to be remarked that few or no people will
have experienced exposure to smoke from the derailment, given
the distance to the accident site and the wind direction, blowing
away from the evacuated zone (Fig. 1). Hence, there is no basis to
conclude that an increased exposure to e.g. dust or smoke took
place. Third, the reporting of symptoms by residents with lower
CEV concentrations may be suggestive for anxiety and mass socio-
genic illness, or induced by communication. Indeed, in the media,
in which the derailment received extensive coverage during mul-
tiple days, irritation was communicated as the most important
symptom that may be experienced following exposure to ACN.
Among the systemic symptoms, headache was reported in the
same order of magnitude as the local symptoms, i.e. by 40–60% of
the residents. Nausea and tremor were reported by less than 20%
of the residents. In non-smokers, a (monotonous) dose-response
relationship was seen between the ACN exposure at the time of
the train accident and the reporting of nausea. The results for
nausea, however, were less conclusive than for irritation: the
probability to report nausea by non-smokers with CEV con-
centrations above 100 pmol/g globin was lower than for irritation.Fig. 3. Scatterplots of CEV concentratFurthermore, both absence and presence of symptoms was re-
ported by non-smokers with CEV concentrations below the re-
ference value and up to 10 times the reference value. Therefore,
nausea seems to be a less sensitive symptom than irritation in case
of higher ACN exposure and a non-speciﬁc symptom in non- or
less exposed people. For headache and tremor, no dose-response
relationships were observed between ACN exposure at the time of
the train accident and symptom reporting. All three systemic
symptoms may be due to other reasons such as increased stress
and agitation, and are therefore not exclusively related to exposure
to chemical substances.
Out of the 3 non-smoking subpopulations of the EZ, the prob-
ability to report symptoms was clearly higher in the residents that
presented at the emergency services (EZ2 Emerg). In this group,
the highest CEV concentrations were also observed. The pattern of
increased symptom reporting in the EZ2 Emerg, however, was
seen for the whole range of CEV concentrations, and is thus in-
dependently of the dose. This may point to residents who are
more vulnerable to the effects of ACN, e.g. due to underlying
conditions, or to residents who go more easily to the emergency
department, independently of their medical condition. As such,ions by self-reported symptoms.
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presenting at the emergency services is not a good practice from
public health point of view. Although the residents with severe
symptoms were clearly captured, it is unknown how many per-
sons with increased concentrations did not present themselves to
the hospital. This number may be important. On the other hand,
the number of persons that showed up in the hospitals without
clear exposure-associated symptoms is unclear (Gunnell, 1993). A
similar phenomenon was observed in persons contacting an
emergency helpline that was installed by the health authorities
following a chemical contamination of the water supply. Fone and
co-workers concluded that the helpline was primarily used by
people who were ‘worried well’, regardless of the incident or any
exposure that had occurred (Fone et al., 1998).
Symptoms in the present study, as with any other study like
this, were not scored by a medical doctor, but were self-reported
by the person involved. Furthermore, the questionnaire was dis-
tributed at the moment of the blood and urine sampling, thus
between days 14 and 21 after the accident. This may have led to
some information bias.
A signiﬁcant association between CEV concentrations at the
time of the accident and short-term health effects was found in
non-smokers, but not in smokers. This lack of association in
smokers may be caused by the higher background CEV con-
centrations in this population. Furthermore, smokers are more
exposed to vapours of chemicals triggering irritation and there-
fore, a further increase in irritation due to ACN exposure may not
be perceived by this population group.
Scientiﬁc studies in the acute context of public health emer-
gencies are limited. When a crisis occurs, the ﬁrst priority is the
management of the crisis, science lagging far behind. Some studies
have reported on the occurrence of self-reported health symptoms
following chemical incidents (Sim et al., 2010; Na et al., 2013;
Tjalvin et al., 2015; Wilken et al., 2015), or on the relationship
between health surveys and chemical exposures as measured in
environmental matrices (Fowle et al., 1996; Arnedo-Pena et al.,
2003). In general, the validity of self-reported symptoms in ex-
posure assessment is subject to information bias by phenomena as
anxiety and mass socio-genic illness (Gallay et al., 2002). Even in
well-designed case-control studies, it is difﬁcult to interpret
whether an increased exposure reported by the cases as compared
to the controls, points to a true increase of exposure or is due to
bias. Selection of cases and controls in such studies is usually done
based on self-reported symptoms, cases being persons who report
symptoms and controls being persons who report no or less
symptoms. Consequently, there is always an uncertainty due to the
fact that persons considered as ‘cases’ are just self-reporting more
symptoms and exposure than persons included in the control
group (Nemery et al., 2002). In our study, we had the opportunity
to investigate the relationships between self-reported symptoms
and individual exposure to chemical contaminants as directly
measured by biomarkers. Our study conﬁrms the limited value of
self-reported symptoms to assess exposure, with exception of
some local symptoms that are known to be prominent for the
speciﬁc chemical compound studied. Even then, the reporting of
symptoms was only absolute in case of exposures that resulted in
CEV values exceeding 10 times the reference value. For the lower
exposure ranges, there was no clear relationship between symp-
tom reporting and exposure. From a public health point of view,
however, it is relevant to know whether persons have been ex-
posed, even at low or moderate concentrations (Hahn et al., 2012).
In conclusion, the present study is one of the ﬁrst to relate
exposure levels to a chemical released during a chemical incident
to short-term (self-reported) health effects. A thorough analysis of
exposure and effects allowed for an adequate scientiﬁc evaluation
of the health impact in connection with the accident, and provideda basis for a fact-based public communication. The results of this
study conﬁrm that a critical view should be taken when con-
sidering self-reported health complaints and effects in the after-
math of a chemical disaster and that ideally biomarkers are
monitored to allow an objective assessment of exposure.Acknowledgements
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